Answers are grounded in this paper and cite their sources.
Managing toxic multinodular goiter in elderly patients can be challenging as age, presence of chronic disease, polypharmacy, and poor medication compliance can limit the use of surgery and long-term antithyroid drugs. Treatment with 131I may not produce the best outcome in states of low radioiodine uptake. Recombinant human thyroid-stimulating hormone (rh-TSH, Thyrogen) used as pretreatment for radioiodine therapy, however, can be useful in this clinical scenario. We report a patient successfully treated (a 94-year-old man on polypharmacy for multiple medical conditions) with radioiodine after pretreatment with rh-TSH. The radioiodine uptake increased with rh-TSH administration and allowed successful treatment with 15.4 mCu of 131I. Recovery from hyperthyroidism was associated with a 71% reduction in the size of thyroid gland by sonography.
No takes yet. Share an insight, caveat, or question.
Hema Padmanabhan (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: